fda and tirzepatide RxConnection FDA Ban on Compounded GLP-1

PlexusDx's Precision Peptide Genetic Test identifies your genetic predisposition across 14 metabolic pathways and 150+ insights, including GIPR variants that influence GLP-1 therapy responsiveness

3A, B, PERMANOVA pre-treatment R 2 = 0.03 and p = 0.03

What this means: - HIIT can boost fitness and improve insulin resistance in people with diabesity - Benefits go beyond weight loss, and are important for long-term diabetes care - HIIT is a time-efficient, non-drug strategy that could complement standard treatments #Type2Diabetes #CardiometabolicHealth #HIIT #ClinicalResearch #NonPharmacological Read the full study: To view or add a comment, sign in How to individualize obesity medication treatment depending on obesity-related conditions

Long-Term Safety : We still need more data on long-term effects, especially for non-diabetic patients